Fundraising Fox

Annalisa D'Andrea

Investor

Venture Partner at Longwood Fund

Boston, Massachusetts

Writes $100K – $5M checks · typically $1.5M

About

D'Andrea is a Venture Partner at Longwood Fund with over 25 years of experience in drug discovery, translational medicine, and R&D strategy across biotech and pharmaceutical companies. She has served as Chief Scientific Officer and board director at multiple organizations, leading scientific teams and advising on portfolio strategy, business development, and early-stage drug development. Currently, she focuses on board service and strategic advisory roles supporting companies and investors on translational planning, due diligence, and R&D decision-making.

LinkedIn ↗

Experience

  1. Longwood FundVenture Partnercurrent2021 — presentBoston, Massachusetts, United States
  2. Spero TherapeuticsAdvisorcurrent2026 — presentBoston, MA
  3. ProtaiMember of the Board of Advisorscurrent2025 — present
  4. Immunitas TherapeuticsChief Scientific Officer2024 — 2026United States
  5. Engimmune TherapeuticsIndependent Board Director2023 — 2026Basel, Switzerland
  6. ImmuneIDPresident and Chief Scientific Officer2021 — 2023Waltham, Massachusetts, United States
  7. Kiniksa PharmaceuticalsChief Scientific Officer2019 — 2021Lexington, Massachusetts
  8. RocheVP, Global Head Immunology & Inflammation Discovery, Roche Pharma Research & Early Development2015 — 2019Basel Area, Switzerland
  9. SRI InternationalExecutive Director, Discovery Biology2015Menlo Park, California
  10. SRI InternationalSenior Director Center for Immunology and Infectious Diseases2008 — 2014Menlo Park, CA
  11. SRI InternationalDirector, Center for Immunology2003 — 2007Menlo Park-CA
  12. SRI InternationalSenior Immunologist2000 — 2003Menlo Park-CA
  13. Inflammation Research AssociationSecretary2014 — 2015
  14. Chiron VaccinesConsultant1998 — 2000Siena-Italy
  15. DNAX Research InstitutePost Doctoral Fellow1994 — 1997Palo Alto-CA
  16. The Wistar InstituteGraduate Student1991 — 1994

Education

  1. University of PennsylvaniaGraduate Student, Immunology1991 — 1994
  2. Università degli Studi di FirenzePhD, Immunology1990 — 1994
  3. Università di SienaMaster in Biology, Microbiology and Immunology1983 — 1987

Skills & more

ManagementStrategic PlanningLeadershipBoard RelationsExecutive LeadershipLifesciences6Infectious Diseases4Biotechnology8Technology TransferBiopharmaceuticals3CommercializationImmunology27
+10 moreCell BiologyAutoimmune DiseasesInflammationVaccinespreclinical developmentIn VitroAssay DevelopmentFlow CytometryELISAPharmaceutical Industry

Languages Italian

From Annalisa's professional profile.

Same school

Also attended University of Pennsylvania607

Dasha MaggioPartner at Felicis Ventures, writer on venture capital and founder psychologyNancy WangInvestor at Felicis VenturesEghosa OmoiguiFounder and Managing General Partner at EchoVC PartnersAkshat GoenkaInvestor at Moonfire VenturesJames KuklinskiInvestor at Spark CapitalKerry KilleenAssociate General Counsel at Revolution

+ 601 more

Also attended Università degli Studi di Firenze15

Robin LiInvestor at GGV CapitalFrancesca PirasSenior Office & HR Manager Americas at PICUS CAPITALLeah ScanlanPartner, Talent at Oak HC/FTMoritz BeissenhirtzInvestment Director Life Sciences at Brandenburg KapitalMatthias SchanzeGeneral Partner at Rethink VenturesEva de MolFounding Partner at CapitalT

+ 9 more

Also attended Università di Siena5

Dr. Leopold von Schlenk-BarnsdorfAdvisor in Value Creation at AuxxoGerard CunninghamOperating Partner at Adjuvant CapitalFrancesca NataliResearch Angel at META GroupDenita AhmetspahicIntern, Operations & Ecosystem Support at XPRENEURSNiko HemsScout at LvlUp Ventures

Shared employers

Also worked at Immunitas Therapeutics4

Anna TuretskyGeneral Partner, PxB Fund at Osage University PartnersKeno GutierrezGeneral Partner at BioGeneration VenturesFabio PucciPartner at Arkin CapitalLucio IannoneVice President at Leaps by Bayer

Also worked at Roche75

Joseph HorsmanInvestor at Madrona Venture GroupMarco PrunottoInvestor at MedicxiMike FitzgeraldInvestor at High AlphaUri LopatinInvestor at Khosla VenturesJan-Olivier FillolsSenior Managing Director at Marlin Equity PartnersNarges BaniasadiVenture Partner at Think+ Ventures Management, Llc

+ 69 more

Also worked at Chiron Vaccines9

Alexia PerouseManaging Partner and CEO at iBionextDion MadsenPartner at Amplitude Venture CapitalKristin Torres MowatPartner at Health Velocity CapitalPeter ThompsonGeneral Partner at OrbiMedRebecca LuciaPartner at 5AM VenturesSamantha TruexInvestor at Avalo Therapeutics

+ 3 more

Also worked at The Wistar Institute4

László ÜrgeChief Business Development Officer at DBH Investment Zrt.Carolyn MagillVenture Partner at Define VenturesKerry BlatneyAssociate at Brighton Park CapitalUciane ScarlettPrincipal at MPM Capital

Colleagues at Longwood Fund

Al Sandrock
Strategic Advisory Board at Longwood Fund
Aleks Radovic-Moreno
Partner at Longwood Fund
Alex Margolin
Venture Partner at Longwood Fund
Annalisa D’Andrea
Venture Partner at Longwood Fund
Anne Klibanski
Strategic Advisory Board at Longwood Fund
Annie Vemu
Senior Associate at Longwood Fund
Aparaajita Balaji
Associate at Longwood Fund
Arielle Jackson
Head, Corporate Communications & Industry Engagement at Longwood Fund

Network5

Aleks Radovic-Moreno
Partner at Longwood Fund
Annie Vemu
Senior Associate at Longwood Fund
David Steinberg
General Partner at Longwood Fund
John Pribis
Principal at Longwood Fund
Lizzie Ngo
Principal at Longwood Fund

Investors connected to Annalisa in public investor directories — a warm-intro map.